NervGen Pharma Corp. (NGEN)
1.78
+0.02
(+1.14%)
USD |
NASDAQ |
Oct 02, 16:00
1.82
+0.04
(+2.25%)
After-Hours: 20:00
NervGen Pharma Net Income (Quarterly) : -21.10M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -21.10M |
| March 31, 2026 | -1.222M |
| December 31, 2025 | -19.30M |
| September 30, 2025 | -3.018M |
| June 30, 2025 | -6.575M |
| March 31, 2025 | -2.752M |
| December 31, 2024 | -6.156M |
| September 30, 2024 | -3.831M |
| June 30, 2024 | -5.720M |
| March 31, 2024 | -1.739M |
| December 31, 2023 | -6.321M |
| September 30, 2023 | -3.209M |
| June 30, 2023 | -3.545M |
| March 31, 2023 | -3.482M |
| December 31, 2022 | -4.375M |
| Date | Value |
|---|---|
| September 30, 2022 | -2.677M |
| June 30, 2022 | -4.952M |
| March 31, 2022 | -3.922M |
| December 31, 2021 | -3.290M |
| September 30, 2021 | -2.857M |
| June 30, 2021 | -2.224M |
| March 31, 2021 | -1.775M |
| December 31, 2020 | -3.508M |
| September 30, 2020 | -1.600M |
| June 30, 2020 | -1.891M |
| March 31, 2020 | -1.382M |
| December 31, 2019 | -2.188M |
| September 30, 2019 | -1.765M |
| June 30, 2019 | -1.140M |
| March 31, 2019 | -2.273M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| InMed Pharmaceuticals, Inc. | -4.843M |
| Milestone Pharmaceuticals, Inc. | -28.61M |
| Clearmind Medicine, Inc. | -0.9073M |
| Lexaria Bioscience Corp. | -1.993M |
| Target Group, Inc. (Canada) | -0.2398M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 21.10M |
| EPS Diluted (Quarterly) | -0.2283 |
| Enterprise Value | 128.24M |
| Earnings Yield | -30.11% |
| Normalized Earnings Yield | -19.56 |